These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15198160

  • 1. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
    Hübler J, Szántó A, Könyves K.
    Int Urol Nephrol; 2003; 35(4):519-21. PubMed ID: 15198160
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Priapism induced by intracavernous injection].
    Morales Concepción JC.
    Arch Esp Urol; 1992 Oct; 45(8):793-5. PubMed ID: 1466580
    [Abstract] [Full Text] [Related]

  • 4. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG, Gilbert P, Wetterhauer U, Bähren W, Thon W, Altwein JE.
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
    Papadopoulos I, Weichert-Jacobsen K, Wand H.
    Z Urol Nephrol; 1990 May; 83(5):233-7. PubMed ID: 2392883
    [Abstract] [Full Text] [Related]

  • 7. Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects.
    Shamloul R, Atteya A, Elnashaar A, Gadallah A, Zohdy W, Abdelsalam W.
    J Sex Med; 2005 Jan; 2(1):117-20. PubMed ID: 16422914
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
    McMahon CG.
    Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R, Mohamed K, Akhras AA, Rashwan H.
    Int J Impot Res; 2005 Oct; 17(4):346-53. PubMed ID: 15772683
    [Abstract] [Full Text] [Related]

  • 16. [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
    Schrey A.
    Fortschr Med; 1990 Oct 20; 108(30):577-80. PubMed ID: 2245960
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risks of self-injection therapy for impotence.
    Millard RJ, Stricker PD, Lynch WJ, Dean TE, Murnaghan GF, Breslin FH.
    Med J Aust; 1996 Jul 15; 165(2):117-8. PubMed ID: 8692055
    [No Abstract] [Full Text] [Related]

  • 19. Induced priapism and its management.
    Török A, Jilling A, Götz F.
    Int Urol Nephrol; 1991 Jul 15; 23(2):191-4. PubMed ID: 1864717
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.